RBRituparna Bhaduri

Rituparna Bhaduri

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rituparna Bhaduri has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Anticancer Activity of Picolinamide and Sulfur Chelated Pt(II) Complexes Against Breast Cancer: In Vitro Interaction Studies Through Molecular Docking With Bio‐Receptors

    by Sharmistha Chatterjee, Saikat Mandal, Chandrika Das, Rituparna Bhaduri, Arka Bagchi, Arunima Biswas, Sankar Ch. Moi

    Herein, picolinamide (pica) and sulfur chelated Pt(II) complexes were focused to investigate for their bioactivity and cytotoxic property. For better anticancer activity and less toxicity of Pt(II) complex, l ‐cysteine (L‐cys) and N‐acetyl‐ l ‐cysteine (N‐acetyl‐ l ‐cys) were used to synthesize Pt(II) complexes. Complex [Pt(pica)(OH 2 ) 2 ](NO 3 ) 2 , C‐2 was obtained on hydrolysis of [Pt(pica)Cl 2 ], C‐1 . The complex [Pt(pica)( l ‐cys)] + ; C‐3 and [Pt(pica)(N‐ac‐ l ‐cys)]; C‐4 were synthesized from C‐2 with thiols l ‐cys and N‐ac‐ l ‐cys, respectively. The binding activity of Pt(II) complexes with DNA and BSA were performed for their binding mode and binding constants. The binding modes of the Pt(II) complexes were executed by electronic and fluorescence spectroscopic methods. Synchronous and 3D fluorescence spectroscopic investigations were performed to observe the insight interaction and conformational change of BSA, when interacts with the complex. The drug likeness property was conducted by PASS prediction and ADMET software programs. Molecular docking of the complexes was carried out with DNA, HSA, and HER‐2 cancer protein. The cytotoxic activity of the complexes was tested on breast cancer cell lines; MCF‐7, MDA MB‐231 and normal human embryonic kidney HEK293T cells. Necrotic cell death mechanism was confirmed by Annexin‐V‐FITC/PI assay by flow cytometric method and the production of reactive oxygen species (ROS) was assessed through DCFDA assay.


  • Anticancer property and normal cell toxicity profile of pyrrolidine‐based platinum (II) complexes: Their DNA, BSA interaction, and molecular docking

    by Swarup Kumar Tarai, Angana Pan, Sriparna Das, Rituparna Bhaduri, Saikat Mandal, Sudipta Maitra, Sankar Chandra Moi

    The bioactivity and cytotoxic property of cis‐[Pt (AEP)Cl2] (C‐1); [Pt (AEP)(OH2)2](NO3)2 (C‐2); [Pt (AEP)(GSH) (C‐3)]; and [Pt (AEP)(DL‐meth)]2+(C‐4) (where AEP = 1‐[2‐Aminoethyl] pyrrolidine; GSH = Glutathione; DL‐meth = DL‐methionine) were extensively investigated to find out the more active and less toxic anticancer lead molecules. Spectroscopically characterized Pt (II) complexes (C‐1 to C‐4) were under investigation for their anticancer activity and bio‐molecular interaction with DNA and BSA. The binding property of the complexes toward DNA and BSA were evaluated by UV–Vis, fluorescence spectroscopy, gel electrophoresis, cyclic voltammetry (CV), circular dichroism (CD), and viscometric methods for their pharmacokinetic and pharmacodynamics importance. The BSA binding activity as well as their “Drug reservoir” property of Pt (II) complexes were highlighted for their biological significance. Furthermore, to assess the manner of interaction and also binding strength of the complexes with DNA and BSA molecule, a theoretical approach by molecular docking was performed, utilizing the optimized structure of the complexes. Structural optimization has been performed with density functional theory (DFT) correlation functional (B3LYP) at 6‐31G + (d, p) and LANL2DZ basis set was used for C, N, H, O, S, and metal, respectively. In vitro anticancer activity and level of ROS generation in presence of each complex were explored on A549 cancer cell as well as normal human cell lines HEK293, and their potential cytotoxic property was observed as compared to well‐known recognized anticancer cisplatin.


  • Anticancer activity and biomolecular interaction of Pt(II) complexes: Their synthesis, characterisation and DFT study

    by Saikat Mandal, Venkata P. Reddy B., Ishani Mitra, Subhajit Mukherjee, Swarup Kumar Tarai, Rituparna Bhaduri, Angana Pan, Jagadeesh C. Bose K., Goutam Kr. Ghosh, Sankar Chandra Moi

    Cis‐[Pt (TEEDA)Cl2]; 1 (where TEEDA = N,N,N′‐triethylethylenediamine) was synthesised, and its SCXRD structure was determined. Complex 1 crystallises in the monoclinic space group I2/a; (z = 8) and unit cell parameters are a = 15.1919(4) Å; b = 9.6049(3) Å; c = 16.7825 Å; α = 90.00°; β = 94.784(3)° and γ = 90.00°. Complex 1 was hydrolysed to diaqua species cis‐[Pt (TEEDA)(H2O)2]2+; 2 L‐cysteine (L‐cys) and N‐acetyl‐L‐cysteine (N‐ac‐L‐cys) chelated complex cis‐[Pt (TEEDA)(L‐cys)]+ 3 and cis‐[Pt (TEEDA)(N‐ac‐L‐cys)] 4 were synthesised and characterised by spectroscopic methods. Kinetic study of substitution reactions of Complex 2 to Complexes 3 and 4 have been explored with the thiols L‐cys and N‐ac‐L‐cys, respectively. The theoretical study with density functional theory (DFT) has been considered to optimise the structures of Complexes 1–4 for HOMO–LUMO energy calculation, TD‐DFT simulation and natural bond orbital (NBO) analysis to support structural characterisation of the complexes. Various electronic properties, known as DFT‐based descriptors, have been calculated from frontier molecular orbital energies to correlate with the adduct formation aptitude of the complexes with DNA and BSA. The binding aptitude and binding mode of the complexes with DNA and BSA have been performed by UV‐Vis and spectrofluorometric titration methods. To observe the interaction of the complexes with CT‐DNA, gel electrophoresis experiment has been carried out. A molecular docking study of the complexes was performed with DNA and BSA. The anticancer activity and ROS generation of the complexes were investigated on different cancer cell lines and fibroblast cells with DCF‐DA using FITC filter.


  • Drug reservoir mechanism of Pt(II)-sulfur chelates based on pharmacokinetics of Pt(II) complex with thiols & thio-ethers: An experimental and theoretical approach

    by Swarup Kumar Tarai, Rituparna Bhaduri, Subhajit Mukherjee, Saikat Mandal, Venkata Pera Reddy B, Sankar Ch. Moi